Neuroblastoma RAS viral oncogene homolog

Neuroblastoma RAS viral (v-ras) oncogene homolog
	; PDB rendering based on 121p.
Available structures
PDB	121p, 1aa9, 1agp, 1bkd, 1clu, 1crp, 1crq, 1crr, 1ctq, 1gnp, 1gnq, 1gnr, 1he8, 1iaq, 1ioz, 1jah, 1jai, 1k8r, 1lf0, 1lf5, 1lfd, 1nvu, 1nvv, 1nvw, 1nvx, 1p2s, 1p2t, 1p2u, 1p2v, 1plj, 1plk, 1pll, 1q21, 1qra, 1rvd, 1wq1, 1xcm, 1xd2, 1xj0, 1zvq, 1zw6, 221p, 2c5l, 2ce2, 2cl0, 2cl6, 2cl7, 2clc, 2cld, 2evw, 2pmx, 421p, 521p, 5p21, 621p, 6q21, 721p, 821p
Identifiers
Symbols	NRAS; ALPS4; N-ras; NRAS1; NS6
External IDs	OMIM: 164790 MGI: 97376 HomoloGene: 55661 GeneCards: NRAS Gene
Gene Ontology
Molecular function	• nucleotide binding; • GTPase activity; • GTP binding;
Cellular component	• Golgi membrane; • intracellular; • Golgi apparatus; • plasma membrane; • plasma membrane;
Biological process	• MAPKKK cascade; • activation of MAPKK activity; • signal transduction; • epidermal growth factor receptor signaling pathway; • small GTPase mediated signal transduction; • Ras protein signal transduction; • axon guidance; • blood coagulation; • insulin receptor signaling pathway; • nerve growth factor receptor signaling pathway; • leukocyte migration;
	Sources: Amigo / QuickGO
Orthologs

From Wikipedia, the free encyclopedia

Jump to: navigation, search

NRAS is an enzyme that in humans is encoded by the NRAS gene. It was discovered ^[1]^[2] by researchers at the Institute of Cancer Research, funded by the Imperial Cancer Research Fund (now Cancer Research UK), and named NRAS, for its initial identification in human neuroblastoma cells.

The N-ras oncogene is a member of the Ras gene family. It is mapped on chromosome 1, and it is activated in HL60, a promyelocytic leukemia line. The order of nearby genes is as follows: cen--CD2--NGFB--NRAS--tel. The mammalian ras gene family consists of the harvey and kirsten ras genes (HRAS and KRAS), an inactive pseudogene of each (c-Hras2 and c-Kras1) and the N-ras gene. They differ significantly only in the C-terminal 40 amino acids. These ras genes have GTP/GDP binding and GTPase activity, and their normal function may be as G-like regulatory proteins involved in the normal control of cell growth. Mutations which change amino acid residues 12, 13 or 61 activate the potential of N-ras to transform cultured cells and are implicated in a variety of human tumors. The N-ras gene specifies two main transcripts of 2Kb and 4.3Kb. The difference between the two transcripts is a simple extension through the termination site of the 2Kb transcript. The N-ras gene consists of seven exons (-I, I, II, III, IV, V, VI). The smaller 2Kb transcript contains the VIa exon, and the larger 4.3Kb transcript contains the VIb exon which is just a longer form of the VIa exon. Both transcripts encode identical proteins as they differ only the 3' untranslated region. The sequence of the shorter 2Kb transcript is presented here. The 4.3 Kb transcript sequence is not available.^[3]

[edit] References

^ Marshall, C. J.; Hall, A.; Weiss, R. A. (1982). "A transforming gene present in human sarcoma cell lines". Nature 299 (5879): 171–173. doi:10.1038/299171a0. ISSN 0028-0836.
^ Hall, Alan; Marshall, Christopher J.; Spurr, Nigel K.; Weiss, Robin A. (1983). "Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1". Nature 303 (5916): 396–400. doi:10.1038/303396a0. ISSN 0028-0836.
^ "Entrez Gene: NRAS neuroblastoma RAS viral (v-ras) oncogene homolog". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4893.

[edit] Further reading

McCormick F (1996). "Ras-related proteins in signal transduction and growth control.". Mol. Reprod. Dev. 42 (4): 500–6. doi:10.1002/mrd.1080420419. PMID 8607982.
van Elsas A, Scheibenbogen C, van der Minne C, et al. (1998). "UV-induced N-ras mutations are T-cell targets in human melanoma.". Melanoma Res. 7 Suppl 2: S107–13. PMID 9578425.
Dracopoli NC, Meisler MH (1990). "Mapping the human amylase gene cluster on the proximal short arm of chromosome 1 using a highly informative (CA)n repeat.". Genomics 7 (1): 97–102. doi:10.1016/0888-7543(90)90523-W. PMID 1692298.
Yuasa Y, Kamiyama T, Kato M, et al. (1990). "Transforming genes from familial adenomatous polyposis patient cells detected by a tumorigenicity assay.". Oncogene 5 (4): 589–96. PMID 1970154.
Hancock JF, Magee AI, Childs JE, Marshall CJ (1989). "All ras proteins are polyisoprenylated but only some are palmitoylated.". Cell 57 (7): 1167–77. doi:10.1016/0092-8674(89)90054-8. PMID 2661017.
Hall A, Brown R (1985). "Human N-ras: cDNA cloning and gene structure.". Nucleic Acids Res. 13 (14): 5255–68. doi:10.1093/nar/13.14.5255. PMC 321863. PMID 2991860. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=321863.
Hirai H, Tanaka S, Azuma M, et al. (1986). "Transforming genes in human leukemia cells.". Blood 66 (6): 1371–8. PMID 2998510.
Neri A, Knowles DM, Greco A, et al. (1988). "Analysis of RAS oncogene mutations in human lymphoid malignancies.". Proc. Natl. Acad. Sci. U.S.A. 85 (23): 9268–72. doi:10.1073/pnas.85.23.9268. PMC 282720. PMID 3057505. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=282720.
Nitta N, Ochiai M, Nagao M, Sugimura T (1987). "Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.". Jpn. J. Cancer Res. 78 (1): 21–6. PMID 3102434.
Raybaud F, Noguchi T, Marics I, et al. (1988). "Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.". Cancer Res. 48 (4): 950–3. PMID 3276402.
Hirai H, Kobayashi Y, Mano H, et al. (1987). "A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.". Nature 327 (6121): 430–2. doi:10.1038/327430a0. PMID 3295562.
Gambke C, Hall A, Moroni C (1985). "Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.". Proc. Natl. Acad. Sci. U.S.A. 82 (3): 879–82. doi:10.1073/pnas.82.3.879. PMC 397150. PMID 3856237. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=397150.
Padua RA, Barrass NC, Currie GA (1985). "Activation of N-ras in a human melanoma cell line.". Mol. Cell. Biol. 5 (3): 582–5. PMC 366752. PMID 3887133. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=366752.
Brown R, Marshall CJ, Pennie SG, Hall A (1984). "Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080.". EMBO J. 3 (6): 1321–6. PMC 557516. PMID 6086315. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=557516.
Yuasa Y, Gol RA, Chang A, et al. (1984). "Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells.". Proc. Natl. Acad. Sci. U.S.A. 81 (12): 3670–4. doi:10.1073/pnas.81.12.3670. PMC 345280. PMID 6587382. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=345280.
Taparowsky E, Shimizu K, Goldfarb M, Wigler M (1983). "Structure and activation of the human N-ras gene.". Cell 34 (2): 581–6. doi:10.1016/0092-8674(83)90390-2. PMID 6616621.
Mitchell EL, Jones D, White GR, et al. (1995). "Determination of the gene order of the three loci CD2, NGFB, and NRAS at human chromosome band 1p13 and refinement of their localisation at the subband level by fluorescence in situ hybridisation.". Cytogenet. Cell Genet. 70 (3–4): 183–5. doi:10.1159/000134028. PMID 7789166.
Kodaki T, Woscholski R, Hallberg B, et al. (1995). "The activation of phosphatidylinositol 3-kinase by Ras". Curr. Biol. 4 (9): 798–806. doi:10.1016/S0960-9822(00)00177-9. PMID 7820549.
Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, et al. (1996). "Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation". EMBO J. 15 (10): 2442–51. PMC 450176. PMID 8665852. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=450176.